leisure time -WSS

leisure time

author：focus 2025-10-01 05:39:14 - browse：9388

Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT — Adobe

Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Why Sanofi got shellacked over its spinoff

explore

hotspot

WSS

Tesla recalling nearly 16,000 of its 2021

Vir antibody drug aimed at influenza A fails in clinical trial

Chimpanzees, like humans and whales, get menopause: Study

The pink breast cancer awareness ribbon needs a redesign

Medtronic CEO on promising devices for diabetes, hypertension

Driven by the pandemic, applicants flood public health schools

Wikipedia

leisure time

explore

How to save PrEP access — and even expand it

Readout Newsletter: XBI biotech index, Akero Therapeutics

As demand for Covid shots wanes, Moderna seeks its next success

Affordable Connectivity Program vital to health care, experts say

At least 13 dead in Texas as scorching temps continue

DeSantis talks Trump, trans issues and 'what wokeness is'

Dobbs anniversary: the lost opportunity of abortion as health care

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Apple is now the first public company to be valued at $3 trillion

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Wikipedia

Biden's order seeks to regulate AI risk without stifling innovation

DeSantis talks Trump, trans issues and 'what wokeness is'

Tocagen's brain cancer gene therapy trial continues. Investors worry

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

The pink breast cancer awareness ribbon needs a redesign

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

explore

explore

hotspot

focus